Availability and reimbursement of biological products for severe asthma in Bulgaria

OBJECTIVES: This study aims to analyze the reimbursement and cost of biological therapy for severe asthma in Bulgaria during 2014–2019 from the perspective of the National Health Insurance Fund. METHODS: It is a retrospective, Marco-costing, top-down study of the expenditures for biological products...

Descripción completa

Detalles Bibliográficos
Autores principales: Milushewa, Petya, Doneva, Miglena, Petrova, Guenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446259/
https://www.ncbi.nlm.nih.gov/pubmed/32922787
http://dx.doi.org/10.1177/2050312120951067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446259/
https://www.ncbi.nlm.nih.gov/pubmed/32922787
http://dx.doi.org/10.1177/2050312120951067

Ejemplares similares